newsfilter
← Latest News
ACCESS Newswire·

Altamira Therapeutics Announces Pricing of $5.0 Million Public Offering

HAMILTON, BERMUDA / ACCESSWIRE / July 6, 2023 / Altamira Therapeutics Ltd. , a company dedicated to developing and commercializing RNA delivery technology for targets beyond the liver,